Comment
|
To investigate the underlying molecular mechanism for the three identified IGT metabolites, their associations with T2D-related genes were studied by analyzing protein-metabolite interaction networks. In all, 7 out of the 46 known T2D-related genes (PPARG, TCF7L2, HNF1A, GCK, IGF1, IRS1 and IDE) were linked to these metabolites through related enzymes or proteins.
|
Formal Description Interaction-ID: 34713
|
|
Drugbank entries
|
Show/Hide entries for
PPARG
or
Glycine
|
Drugbank
DB00159
|
|
Drugbank
DB00197
|
|
Drugbank
DB00244
|
|
Drugbank
DB00328
|
|
Drugbank
DB00412
|
|
Drugbank
DB00731
|
|
Drugbank
DB00795
|
|
Drugbank
DB00912
|
|
Drugbank
DB00966
|
|
Drugbank
DB01014
|
|
Drugbank
DB01067
|
|
Drugbank
DB01132
|
|
Drugbank
DB01252
|
|
Drugbank
DB01393
|
|
Drugbank
DB04270
|
(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl ...
|
Drugbank
DB04689
|
2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2- ...
|
Drugbank
DB06908
|
(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL- ...
|
Drugbank
DB06926
|
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-die ...
|
Drugbank
DB07053
|
2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO ...
|
Drugbank
DB07111
|
(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydoco ...
|
Drugbank
DB07172
|
(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6, ...
|
Drugbank
DB07208
|
(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8, ...
|
Drugbank
DB07209
|
(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12 ...
|
Drugbank
DB07302
|
(9S,10E,12Z)-9-hydroxyoctadeca-10,12-die ...
|
Drugbank
DB07509
|
difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-k ...
|
Drugbank
DB07675
|
(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10 ...
|
Drugbank
DB07723
|
3-(5-methoxy-1H-indol-3-yl)propanoic aci ...
|
Drugbank
DB07724
|
3-{5-methoxy-1-[(4-methoxyphenyl)sulfony ...
|
Drugbank
DB07842
|
(2S)-2-(4-ethylphenoxy)-3-phenylpropanoi ...
|
Drugbank
DB07863
|
2-chloro-5-nitro-N-phenylbenzamide
|
Drugbank
DB08121
|
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropan ...
|
Drugbank
DB08302
|
3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]b ...
|
Drugbank
DB08402
|
2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMI ...
|
Drugbank
DB08435
|
(5E,14E)-11-oxoprosta-5,9,12,14-tetraen- ...
|
Drugbank
DB08483
|
(2S)-2-methoxy-3-{4-[2-(5-methyl-2-pheny ...
|
Drugbank
DB08560
|
3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIE ...
|
Drugbank
DB08760
|
(2S)-2-(4-chlorophenoxy)-3-phenylpropano ...
|
Drugbank
DB00197
|
|
Drugbank
DB00412
|
|
Drugbank
DB01132
|
|
Drugbank
DB04689
|
2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2- ...
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
Drugbank
DB00145
|
|
|
|